Friday, December 28, 2012

• An Interview with Andrew Sleeman, Portfolio Manager and Research Analyst at Franklin Mutual Advisers Reveals His Top Picks in Asia Pac & European StocksWall Street Transcript (Fri, Dec 28)

Thursday, December 27, 2012

• Mylan’s Suit Against the FDA Dismissed, Cardica Ships MicroCutter: Healthcare Business Updateat Wall St. Cheat Sheet (Thu, Dec 27)
• EU Approval for Novartis' ExjadeZacks (Thu, Dec 27)
• Dendreon Sells Manufacturing UnitZacks (Thu, Dec 27)
• The Most Important New Drug Of 2012at Forbes (Thu, Dec 27)

Wednesday, December 26, 2012

• Is Eli Lilly in Good Hands?at Motley Fool (Wed, Dec 26)
• Cooper Downgraded to NeutralZacks (Wed, Dec 26)
• Comparing Dividend Payout Ratios Across Regionsat Seeking Alpha (Wed, Dec 26)
• [video] Health Care Prescription For Your Portfolioat CNBC (Wed, Dec 26)

Monday, December 24, 2012

• A Smart Buy On MS And Hemophilia Treatments?at Motley Fool (Mon, Dec 24)
• Northwest Biotherapeutics Raises $12M And Uplists To Nasdaqat Seeking Alpha (Mon, Dec 24)
• The Zacks Analyst Blog Highlights: Edison International, Dominion Resources, Shire, Johnson & Johnson and NovartisZacks (Mon, Dec 24)
• A Little Known Way To Buy Nestle, Roche And Novartis For 85 Cents On The Dollarat Seeking Alpha (Mon, Dec 24)

Friday, December 21, 2012

• Encouraging News for ShireZacks (Fri, Dec 21)
• Is Regeneron Pharmaceuticals Really Worth More Than $180?at Motley Fool (Fri, Dec 21)
• Dendreon Finds a Buyerat Motley Fool (Fri, Dec 21)
• Novartis AG Stock Buy Recommendation Reiterated (NVS)at TheStreet (Fri, Dec 21)
• Buy Novartis For A Safe Dividend Yieldat Seeking Alpha (Fri, Dec 21)

Thursday, December 20, 2012

• An Analysis of Barron’s 10 Stocks for 2013- Part IIat Motley Fool (Thu, Dec 20)
• Trovagene Grants Genoptix License for NPM1, ACADIA Gets Funding: Healthcare Business Recapat Wall St. Cheat Sheet (Thu, Dec 20)
• J&J's Dividend, Yielding 3.5%: What You Need to Know About Cash and Growthat Forbes (Thu, Dec 20)
• Emerging Markets Health Care -- A Unique Challengeat Motley Fool (Thu, Dec 20)
• The Zacks Analyst Blog Highlights: AstraZeneca, Mylan Pharma, Novartis, Teva Pharmaceuticals and MerckZacks (Thu, Dec 20)

Wednesday, December 19, 2012

• Three Awesome Dividend Playsat Motley Fool (Wed, Dec 19)
• Good News for AstraZenecaZacks (Wed, Dec 19)

Add NVS News to My Yahoo!